from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3693/-

LFCtreatmentdescriptionclass of inhibitor

-0.883

Amikacinug/mL Amikacintranslation

-1.250

Cap5-10ug/mL Capreomycintranslation

-0.993

Rox10-50 ug/mL Roxithromycintranslation

-0.599

SM2-5 ug/mL Streptomycintranslation

-0.935

Tet5-10 ug/mL Tetracyclinetranslation

0.817

Rif0.2-5ug/mL Rifampicintranscription

-0.041

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.371

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.205

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.279

CPZ10-50 ug/mL Chlorpromazinerespiration

0.034

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.557

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.024

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.022

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.060

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.256

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.252

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.931

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.797

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.808

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.525

KCN5-20 ug/mL Potassium cyaniderespiration

0.326

NaN30.2-2 mM Sodium aziderespiration

0.628

Nigericin50 uM Nigericinrespiration

0.069

TRC10-150 ug/mL Triclosanrespiration

0.955

TRZ10-25 ug/mL Thioridazinerespiration

0.974

Valinomycin0.5-10 uM Valinomycinrespiration

-1.243

ZnSO42 mM ZnSO4respiration

1.475

menadione6-10 ug/mL Menadionerespiration

0.802

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.149

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.948

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.398

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.582

NRP_1Non-replicating persistence stage 1dosRassociated

0.079

Amp0.2mg/mL AmpicillincellWall

-0.677

Cephalexin20-100 ug/mL CephalexincellWall

-0.247

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.201

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.259

EMB10-20 ug/mL EthambutolcellWall

-1.184

Eta12-40 ug/mL EthionamidecellWall

-1.368

INH0.2-0.4 ug/mL IsoniazidcellWall

0.150

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.217

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.649

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.061

BZA0.12 mg/mL BenzamidearomaticAmides

-0.304

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.107

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.185

H2O24 mM hydrogen peroxideDNAdamaging

-0.352

Levo10 ug/mL LevofloxacinDNAdamaging

-0.471

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.585

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.783

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.154

UVUV-irradiationDNAdamaging

1.408

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.588

Antimycin12.5-50 ug/mL Antimycin A?

1.099

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.094

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.283

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.211

PA8240.2-2 ug/mL PA-824?

-0.503

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.883

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.967

Verapamil50 uM Verapamil?

0.886

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.066

methoxatin10-20 ug/mL Methoxatin?